{"id":728616,"date":"2023-02-03T09:03:35","date_gmt":"2023-02-03T14:03:35","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/heartsciences-announces-further-internationalization-of-its-patent-portfolio\/"},"modified":"2023-02-03T09:03:35","modified_gmt":"2023-02-03T14:03:35","slug":"heartsciences-announces-further-internationalization-of-its-patent-portfolio","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/heartsciences-announces-further-internationalization-of-its-patent-portfolio\/","title":{"rendered":"HeartSciences Announces Further Internationalization of its Patent Portfolio"},"content":{"rendered":"

\nGranted Korean Patent for its MyoVista\u00ae Wavelet Technology
\n<\/h2>\n
\n

Southlake, Texas, Feb. 03, 2023 (GLOBE NEWSWIRE) — Heart Test Laboratories, Inc.<\/u><\/a> d\/b\/a HeartSciences (NASDAQ: HSCS; HSCSW) (\u201cHeartSciences\u201d or the \u201cCompany\u201d), a medical technology company focused on saving lives by making an ECG (also known as an EKG) a far more valuable screening tool through the use of Artificial Intelligence (AI), today announced it has been granted Korean Patent No. 10-2490960 from the Korean Intellectual Property Office (KIPO). <\/p>\n

To date HeartSciences has been granted nine US patents and 30 international patents for a total of 39 granted patents. \u00a0The Company has nine additional patents pending across the US and international markets.\u00a0 Issued international patents are across key countries including China, Brazil, Canada, India, South Korea, Mexico, and key European markets such as Germany, France, UK, Italy and the Netherlands.<\/p>\n

Andrew Simpson, Chief Executive Officer of HeartSciences, commented, \u201cMillions of ECG\u2019s are performed worldwide every week and the ECG is by far the most ubiquitous cardiac test. The addition of cardiac dysfunction detection to the ECG is expected to provide significant benefit to healthcare providers and health systems around the world. Cardiovascular disease accounts for 17.9 million deaths, an estimated 32% of all deaths worldwide. The MyoVista\u00ae could play a significant role in heart health screening worldwide.\u201d<\/p>\n

Mr. Simpson continued, \u201cGiven the scale of the global market, protection of our intellectual property and patents in major markets is core to the Company as it provides intrinsic value to HeartSciences and would be expected to be a source of major competitive advantage as we move toward commercialization. This latest patent further expands our international coverage and is the latest addition to our extensive patent portfolio.\u201d<\/p>\n

The MyoVista\u00ae is a resting 12-lead electrocardiograph that uses AI and continuous wavelet transform (CWT) signal processing to provide cardiac information associated with left ventricular diastolic dysfunction (LVDD), a condition which has previously not been possible to detect using conventional electrocardiology. It is designed to improve the ability of electrocardiography by using continuous wavelet transform mathematics to extract the frequency content from the input ECG signal.\u00a0 This additional valuable information is used as part of the input in developing the AI models and helps improve overall model performance.<\/p>\n

\n About HeartSciences<\/strong>\n <\/p>\n

Heart Test Laboratories, Inc. d\/b\/a HeartSciences is a medical technology company focused on applying innovative AI-based technology to an ECG (also known as an EKG) to expand and improve an ECG\u2019s clinical usefulness. Millions of ECGs are performed every week and the Company\u2019s objective is to improve healthcare by making an ECG a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. HeartSciences\u2019 first product candidate for FDA clearance, the MyoVista\u00ae wavECG, or the MyoVista\u00ae, is a resting 12-lead ECG that is also designed to provide diagnostic information related to cardiac dysfunction which has traditionally only been available through the use of cardiac imaging. The MyoVista\u00ae also provides conventional ECG information in the same test. The business model, which involves the use of the MyoVista\u00ae device and consumables for each test, is expected to be \u201crazor-razorblade\u201d as the electrodes used with the MyoVista\u00ae are proprietary to HeartSciences, and new electrodes are required for every test performed.<\/p>\n

For more information, please visit:\u00a0https:\/\/www.heartsciences.com<\/u><\/a>. Twitter:\u00a0@HeartSciences<\/u><\/a><\/p>\n

\n Safe Harbor Statement<\/strong>\n <\/p>\n

This announcement contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are made under the \u201csafe harbor\u201d provisions of the Private Securities Litigation Reform Act of 1995 and are relating to the Company’s future financial and operating performance. All statements, other than statements of historical facts, included herein are “forward-looking statements” including, among other things, statements about HeartSciences\u2019 beliefs and expectations. These statements are based on current expectations, assumptions and uncertainties involving judgments about, among other things, future economic, competitive and market conditions and future business decisions, all of which are difficult or impossible to predict accurately and many of which are beyond the Company’s control. The expectations reflected in these forward-looking statements involve significant assumptions, risks and uncertainties, and these expectations may prove to be incorrect. Investors should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Potential risks and uncertainties include, but are not limited to, risks discussed in HeartSciences\u2019 filings with the U.S. Securities and Exchange Commission at www.sec.gov. Other than as required under the securities laws, the Company does not assume a duty to update these forward-looking statements.<\/p>\n

\n For investor and media inquiries, please contact:<\/strong>\n <\/p>\n

\n Investor Relations:<\/em>
\n
Crescendo Communications, LLC
Phone: (212) 671-1021
Email: HSCS@crescendo-ir.com<\/u><\/a><\/p>\n

\n Company:<\/em>
\n
Gene Gephart
Phone: +1-737-414-9213 (US)
Email: investorrelations@heartsciences.com<\/u><\/p>\n


\n
\n \n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

Granted Korean Patent for its MyoVista\u00ae Wavelet Technology Southlake, Texas, Feb. 03, 2023 (GLOBE NEWSWIRE) — Heart Test Laboratories, Inc. d\/b\/a HeartSciences (NASDAQ: HSCS; HSCSW) (\u201cHeartSciences\u201d or the \u201cCompany\u201d), a medical technology company focused on saving lives by making an ECG (also known as an EKG) a far more valuable screening tool through the use of Artificial Intelligence (AI), today announced it has been granted Korean Patent No. 10-2490960 from the Korean Intellectual Property Office (KIPO). To date HeartSciences has been granted nine US patents and 30 international patents for a total of 39 granted patents. \u00a0The Company has nine additional patents pending across the US and international markets.\u00a0 Issued international patents are across key countries including China, Brazil, Canada, … <\/p>\n

Continue reading “HeartSciences Announces Further Internationalization of its Patent Portfolio”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-728616","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nHeartSciences Announces Further Internationalization of its Patent Portfolio - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/heartsciences-announces-further-internationalization-of-its-patent-portfolio\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"HeartSciences Announces Further Internationalization of its Patent Portfolio - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Granted Korean Patent for its MyoVista\u00ae Wavelet Technology Southlake, Texas, Feb. 03, 2023 (GLOBE NEWSWIRE) — Heart Test Laboratories, Inc. d\/b\/a HeartSciences (NASDAQ: HSCS; HSCSW) (\u201cHeartSciences\u201d or the \u201cCompany\u201d), a medical technology company focused on saving lives by making an ECG (also known as an EKG) a far more valuable screening tool through the use of Artificial Intelligence (AI), today announced it has been granted Korean Patent No. 10-2490960 from the Korean Intellectual Property Office (KIPO). To date HeartSciences has been granted nine US patents and 30 international patents for a total of 39 granted patents. \u00a0The Company has nine additional patents pending across the US and international markets.\u00a0 Issued international patents are across key countries including China, Brazil, Canada, … Continue reading "HeartSciences Announces Further Internationalization of its Patent Portfolio"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/heartsciences-announces-further-internationalization-of-its-patent-portfolio\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-02-03T14:03:35+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc0MjIzOCM1Mzg5OTY0IzUwMDEwNTg1Ng==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/heartsciences-announces-further-internationalization-of-its-patent-portfolio\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/heartsciences-announces-further-internationalization-of-its-patent-portfolio\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"HeartSciences Announces Further Internationalization of its Patent Portfolio\",\"datePublished\":\"2023-02-03T14:03:35+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/heartsciences-announces-further-internationalization-of-its-patent-portfolio\\\/\"},\"wordCount\":794,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/heartsciences-announces-further-internationalization-of-its-patent-portfolio\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc0MjIzOCM1Mzg5OTY0IzUwMDEwNTg1Ng==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/heartsciences-announces-further-internationalization-of-its-patent-portfolio\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/heartsciences-announces-further-internationalization-of-its-patent-portfolio\\\/\",\"name\":\"HeartSciences Announces Further Internationalization of its Patent Portfolio - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/heartsciences-announces-further-internationalization-of-its-patent-portfolio\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/heartsciences-announces-further-internationalization-of-its-patent-portfolio\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc0MjIzOCM1Mzg5OTY0IzUwMDEwNTg1Ng==\",\"datePublished\":\"2023-02-03T14:03:35+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/heartsciences-announces-further-internationalization-of-its-patent-portfolio\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/heartsciences-announces-further-internationalization-of-its-patent-portfolio\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/heartsciences-announces-further-internationalization-of-its-patent-portfolio\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc0MjIzOCM1Mzg5OTY0IzUwMDEwNTg1Ng==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc0MjIzOCM1Mzg5OTY0IzUwMDEwNTg1Ng==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/heartsciences-announces-further-internationalization-of-its-patent-portfolio\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"HeartSciences Announces Further Internationalization of its Patent Portfolio\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"HeartSciences Announces Further Internationalization of its Patent Portfolio - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/heartsciences-announces-further-internationalization-of-its-patent-portfolio\/","og_locale":"en_US","og_type":"article","og_title":"HeartSciences Announces Further Internationalization of its Patent Portfolio - Market Newsdesk","og_description":"Granted Korean Patent for its MyoVista\u00ae Wavelet Technology Southlake, Texas, Feb. 03, 2023 (GLOBE NEWSWIRE) — Heart Test Laboratories, Inc. d\/b\/a HeartSciences (NASDAQ: HSCS; HSCSW) (\u201cHeartSciences\u201d or the \u201cCompany\u201d), a medical technology company focused on saving lives by making an ECG (also known as an EKG) a far more valuable screening tool through the use of Artificial Intelligence (AI), today announced it has been granted Korean Patent No. 10-2490960 from the Korean Intellectual Property Office (KIPO). To date HeartSciences has been granted nine US patents and 30 international patents for a total of 39 granted patents. \u00a0The Company has nine additional patents pending across the US and international markets.\u00a0 Issued international patents are across key countries including China, Brazil, Canada, … Continue reading \"HeartSciences Announces Further Internationalization of its Patent Portfolio\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/heartsciences-announces-further-internationalization-of-its-patent-portfolio\/","og_site_name":"Market Newsdesk","article_published_time":"2023-02-03T14:03:35+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc0MjIzOCM1Mzg5OTY0IzUwMDEwNTg1Ng==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/heartsciences-announces-further-internationalization-of-its-patent-portfolio\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/heartsciences-announces-further-internationalization-of-its-patent-portfolio\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"HeartSciences Announces Further Internationalization of its Patent Portfolio","datePublished":"2023-02-03T14:03:35+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/heartsciences-announces-further-internationalization-of-its-patent-portfolio\/"},"wordCount":794,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/heartsciences-announces-further-internationalization-of-its-patent-portfolio\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc0MjIzOCM1Mzg5OTY0IzUwMDEwNTg1Ng==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/heartsciences-announces-further-internationalization-of-its-patent-portfolio\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/heartsciences-announces-further-internationalization-of-its-patent-portfolio\/","name":"HeartSciences Announces Further Internationalization of its Patent Portfolio - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/heartsciences-announces-further-internationalization-of-its-patent-portfolio\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/heartsciences-announces-further-internationalization-of-its-patent-portfolio\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc0MjIzOCM1Mzg5OTY0IzUwMDEwNTg1Ng==","datePublished":"2023-02-03T14:03:35+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/heartsciences-announces-further-internationalization-of-its-patent-portfolio\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/heartsciences-announces-further-internationalization-of-its-patent-portfolio\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/heartsciences-announces-further-internationalization-of-its-patent-portfolio\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc0MjIzOCM1Mzg5OTY0IzUwMDEwNTg1Ng==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc0MjIzOCM1Mzg5OTY0IzUwMDEwNTg1Ng=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/heartsciences-announces-further-internationalization-of-its-patent-portfolio\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"HeartSciences Announces Further Internationalization of its Patent Portfolio"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/728616","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=728616"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/728616\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=728616"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=728616"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=728616"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}